Friday, 25th November 2016
This report covers eight products with particularly impressive products in visualisation and data analytics for organisations operating in the pharmaceutical field:
We provide a brief description of each company and their product/s, a link to the website and product page, examples of customers or use-cases, and a link to Jinfo coverage.
An introductory article, "Revolutionising big pharma with big data, visualisation and analytics" frames the challenges faced by the pharmaceutical industry and how such tools can help to overcome them.
Produced by Dr. Michelle Maxwell
*Clarivate Analytics is formerly the IP & Science business of Thomson Reuters and is no longer part of Thomson Reuters. The change took place in October 2016 and the press announcement and information about the entities behind Clarivate (Onex Corporation and Barings Private Equity Asia) can be found here.
Access to Jinfo reports and articles is a benefit of a Jinfo Subscription.
Please sign in here so that we can check your access to this item:
If this item has been shared with you by someone, we will ask you to quickly set up a free account for Jinfo, before returning you to this page to show you the item.
Gain access to this report, with a Jinfo Subscription. It will help your organisation:
Benefits and Pricing
Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
Claire LaybatsHead of Commercial Developmentclaire.email@example.com
Related Subscription Articles:
Related Blog items:
« All Reports
Login to MyJinfo if you already have a Jinfo Subscription
Focus on Risk Assessment
Risk assessment to gauge the ability of your services, team, portfolio and overall value to withstand stress is a required process for a healthy information department.